Chinese Biotech Bets on AI Fertility Testing as Demand for IVF Rises
Hangzhou Diagens Biotechnology is turning to AI-powered chromosome testing to speed up IVF and tap rising demand in China’s shrinking fertility market. The company hopes the technology will support profit growth after its Hong Kong listing.



















